Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Proietti

Showing results (71-80 of 280) with videos related to

Pageof 28
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2015
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trialMarco Proietti, Valeria Raparelli, Brian Olshansky, et al.
British Journal of Clinical Pharmacology|May 11, 2018
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillationCarlotta Franchi, Stefania Antoniazzi, Marco Proietti, et al.
Hypertension (Dallas, Tex. : 1979)|October 5, 2017
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, et al.
Thrombosis and Haemostasis|May 22, 2015
Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS studyStefania Basili, Marco Proietti, Francesco Perticone, et al.
The Canadian Journal of Cardiology|April 30, 2019
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International GuidelinesMarco Proietti, Deirdre A Lane, Giuseppe Boriani, et al.
Journal of Clinical Medicine|July 2, 2021
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisGiulio Francesco Romiti, Bernadette Corica, Gregory Y H Lip, et al.
The American Journal of Medicine|October 21, 2015
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking WarfarinKeitaro Senoo, Marco Proietti, Deirdre A Lane, et al.
Scientific Reports|April 13, 2016
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk ScoresMarco Proietti, Keitaro Senoo, Deirdre A Lane, et al.
Internal and Emergency Medicine|June 20, 2019
Risk stratification in hospitalized heart failure patients: do the RIGHT thing!Alberto Maria Marra, Marco Proietti, Eduardo Bossone, et al.
Frontiers in Endocrinology|March 13, 2019
The Sex-Specific Detrimental Effect of Diabetes and Gender-Related Factors on Pre-admission Medication Adherence Among Patients Hospitalized for Ischemic Heart Disease: Insights From EVA StudyValeria Raparelli, Marco Proietti, Giulio Francesco Romiti, et al.
Pageof 28

Showing results (71-80 of 280) with videos related to

Sort By:
Pageof 28
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2015
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trialMarco Proietti, Valeria Raparelli, Brian Olshansky, et al.
British Journal of Clinical Pharmacology|May 11, 2018
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillationCarlotta Franchi, Stefania Antoniazzi, Marco Proietti, et al.
Hypertension (Dallas, Tex. : 1979)|October 5, 2017
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management)Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, et al.
Thrombosis and Haemostasis|May 22, 2015
Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS studyStefania Basili, Marco Proietti, Francesco Perticone, et al.
The Canadian Journal of Cardiology|April 30, 2019
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International GuidelinesMarco Proietti, Deirdre A Lane, Giuseppe Boriani, et al.
Journal of Clinical Medicine|July 2, 2021
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisGiulio Francesco Romiti, Bernadette Corica, Gregory Y H Lip, et al.
The American Journal of Medicine|October 21, 2015
Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking WarfarinKeitaro Senoo, Marco Proietti, Deirdre A Lane, et al.
Scientific Reports|April 13, 2016
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk ScoresMarco Proietti, Keitaro Senoo, Deirdre A Lane, et al.
Internal and Emergency Medicine|June 20, 2019
Risk stratification in hospitalized heart failure patients: do the RIGHT thing!Alberto Maria Marra, Marco Proietti, Eduardo Bossone, et al.
Frontiers in Endocrinology|March 13, 2019
The Sex-Specific Detrimental Effect of Diabetes and Gender-Related Factors on Pre-admission Medication Adherence Among Patients Hospitalized for Ischemic Heart Disease: Insights From EVA StudyValeria Raparelli, Marco Proietti, Giulio Francesco Romiti, et al.
Pageof 28